References
- Greenwood Z, Black J, Weld L, et al. Gastrointestinal infection among international travellers globally. J Travel Med. 2008;15:195–202.
- International Travel and Health 2010. WHO. p34 [available on the Internet]. c2011. Available from: http://www.who.int/ith/en
- Baaten GGB, Sonder GJB, Van der Loeff MFS, et al. Fecal-orally transmitted diseases among travellers are decreasing due to better hygienic standards at travel destination. J Travel Med. 2010;17:322–328.
- Siliva FG, Figueiredo A, Varandas L Travellers’ diarrhea in children vieing tropical countries. J Travel Med. 2009;16:53–54.
- Phinger B, Steffen R, Tschopp A. Incidence and clinical features of travellers’ diarrhea in infants and children. Pediatr Infect Dis J. 1991;10:719–723.
- Steffen R, Du Pont HL, Wilder-Smith A. Manual of Travel Medicine and Health. 3rd edition. In: BC Decker, ethtor. 2007.
- Connor B. CDC Health information for international travel 2010. The Yellow Book. New York: Mosby Elsevier, 2009; p.161–166.
- Ko G, Garcia C, Jiang ZD, et al. Noroviruses as a cause of travellers’ diarrhoea among students from the United States visiting Mexico. J Clin Microbial. 2005;43:6126–6129.
- DuPont HL, Ericsson CD, Farthing MJG, et al. Expert review of the evidence base for prevention of travellers’ diarrhoea. J Travel Med. 2009;16:149–160.
- DuPont HL, Ericsson CD, Farthing MJ, et al. Expert review of the evidence base for setherapy for travellers’ diarrhoea. J Travel Med. 2009;16:161–171.
- Connor B. CDC Health information for international travel 2010. The Yellow Book. New York: Mosby Elsevier, 2009; p.280–284.
- Portnoy BL, DuPont HL, Pruitt D, et al. Antidiarrhoeal agents in the treatment of acute diarrhoea in children. JAMA. 1976;236:844–846.
- Johnson PC, Ericsson CD, DuPont HL, et al. Comparison of loperamide with bismuth subsalicylate for the treatment of acute travellers’ diarrhoea. JAMA. 1986;255:755–760.
- Gomi H, Jiang ZD, Adachi JA, et al. In vitro antimicrobial susceptibility testing of bacterial enteropathogens causing travellers’ diarrhoea in four geographic regions. Antimicrob Agents Chemother. 200115: 212–216.
- Fuller JD, Low DE. A review of Streptococcus pneumoniae infection treatment failures associated with fluoroquinolone resistance. Clin Infect Dis. 2005;41:118–121.
- Wardak S, Szych J, Zasada M, Gierczynski R. Antibiotic resistance of Campylobaceter jejuni and Campylobacter coli clinical isolates from Poland. Antimicrob Agents Chemother, 2007;51:1123–1125.
- DuPont HL, Haake R, Taylor DN, et al. Rifaximin treatment of pathogen negative travellers’ diarrhoea. J Travel Med. 2007;14:16–19.
- Forsyth CT, Ernst ME. Do fluoroquinolones commonly cause arthropathy in children? CJEM. 2007;9:459–462.
- Ruuskanen O. Safety and tolerability of azithromycin in paediatric infectious diseases: 2003 update. Pediatr Infect Dis J. 2004;23(2Suppl):S135–S139.
- Hill DR, Ryan ET. Clinical review: management of travellers’ diarrhea. BMJ. 2008;337:a1746.